These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35773527)

  • 1. Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy.
    Álvarez-Varela A; Novellasdemunt L; Barriga FM; Hernando-Momblona X; Cañellas-Socias A; Cano-Crespo S; Sevillano M; Cortina C; Stork D; Morral C; Turon G; Slebe F; Jiménez-Gracia L; Caratù G; Jung P; Stassi G; Heyn H; Tauriello DVF; Mateo L; Tejpar S; Sancho E; Stephan-Otto Attolini C; Batlle E
    Nat Cancer; 2022 Sep; 3(9):1052-1070. PubMed ID: 35773527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the E2F3-MEX3A-KLF4 signaling axis that sustains cancer cells in undifferentiated and proliferative state.
    Yang X; Li G; Tian Y; Wang X; Xu J; Liu R; Deng M; Shao C; Pan Y; Wu X; Li M; Zhang C; Liu R; Qin J; Zhang C; Liu Z; Wu X; Plikus MV; Lengner CJ; Zheng Z; Lv C; Yu Z
    Theranostics; 2022; 12(16):6865-6882. PubMed ID: 36276637
    [No Abstract]   [Full Text] [Related]  

  • 3. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEX3A regulates Lgr5
    Pereira B; Amaral AL; Dias A; Mendes N; Muncan V; Silva AR; Thibert C; Radu AG; David L; Máximo V; van den Brink GR; Billaud M; Almeida R
    EMBO Rep; 2020 Apr; 21(4):e48938. PubMed ID: 32052574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genome editing approach to study cancer stem cells in human tumors.
    Cortina C; Turon G; Stork D; Hernando-Momblona X; Sevillano M; Aguilera M; Tosi S; Merlos-Suárez A; Stephan-Otto Attolini C; Sancho E; Batlle E
    EMBO Mol Med; 2017 Jul; 9(7):869-879. PubMed ID: 28468934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
    Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
    Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer.
    Boos SL; Loevenich LP; Vosberg S; Engleitner T; Öllinger R; Kumbrink J; Rokavec M; Michl M; Greif PA; Jung A; Hermeking H; Neumann J; Kirchner T; Rad R; Jung P
    Cell Mol Gastroenterol Hepatol; 2022; 13(2):517-540. PubMed ID: 34700030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing estrogen-responsive mouse mammary organoids from single Lgr5
    Zhang L; Adileh M; Martin ML; Klingler S; White J; Ma X; Howe LR; Brown AM; Kolesnick R
    Cell Signal; 2017 Jan; 29():41-51. PubMed ID: 27511963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-matrix interface regulates dormancy in human colon cancer stem cells.
    Ohta Y; Fujii M; Takahashi S; Takano A; Nanki K; Matano M; Hanyu H; Saito M; Shimokawa M; Nishikori S; Hatano Y; Ishii R; Sawada K; Machinaga A; Ikeda W; Imamura T; Sato T
    Nature; 2022 Aug; 608(7924):784-794. PubMed ID: 35798028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids.
    Ding L; Yang Y; Lu Q; Cao Z; Weygant N
    Curr Cancer Drug Targets; 2022; 22(3):195-208. PubMed ID: 35078398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
    Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
    Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture.
    Usui T; Sakurai M; Umata K; Elbadawy M; Ohama T; Yamawaki H; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Sato K; Kaneda M; Sasaki K
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer.
    Gregorieff A; Liu Y; Inanlou MR; Khomchuk Y; Wrana JL
    Nature; 2015 Oct; 526(7575):715-8. PubMed ID: 26503053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.
    Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G
    EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D differentially regulates colon stem cells in patient-derived normal and tumor organoids.
    Fernández-Barral A; Costales-Carrera A; Buira SP; Jung P; Ferrer-Mayorga G; Larriba MJ; Bustamante-Madrid P; Domínguez O; Real FX; Guerra-Pastrián L; Lafarga M; García-Olmo D; Cantero R; Del Peso L; Batlle E; Rojo F; Muñoz A; Barbáchano A
    FEBS J; 2020 Jan; 287(1):53-72. PubMed ID: 31306552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse.
    Merlos-Suárez A; Barriga FM; Jung P; Iglesias M; Céspedes MV; Rossell D; Sevillano M; Hernando-Momblona X; da Silva-Diz V; Muñoz P; Clevers H; Sancho E; Mangues R; Batlle E
    Cell Stem Cell; 2011 May; 8(5):511-24. PubMed ID: 21419747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Lgr5-independent spheroid-generating progenitors of the mouse fetal intestinal epithelium.
    Mustata RC; Vasile G; Fernandez-Vallone V; Strollo S; Lefort A; Libert F; Monteyne D; Pérez-Morga D; Vassart G; Garcia MI
    Cell Rep; 2013 Oct; 5(2):421-32. PubMed ID: 24139799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphere‑forming assay vs. organoid culture: Determining long‑term stemness and the chemoresistant capacity of primary colorectal cancer cells.
    Zhao H; Yan C; Hu Y; Mu L; Huang K; Li Q; Li X; Tao D; Qin J
    Int J Oncol; 2019 Mar; 54(3):893-904. PubMed ID: 30664193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.